Coronavirus: Hong Kong calls time-out on AstraZeneca vaccine shipments amid concerns over blood clots, failure to handle new Covid-19 variant

Apr 9, 2021 | INVESTING

Hong Kong has asked embattled drug giant AstraZeneca to delay delivery of its Covid-19 vaccine, and is now looking instead at second-generation drugs that can better handle new coronavirus variants, the city’s health minister has revealed. The city previously ordered 7.5 million doses from the British-Swedish firm, which was originally expected to ship the first batch to Hong Kong in the second half of this year. But AstraZeneca, which co-developed the vaccine with Oxford University, has been…

Read More

Pin It on Pinterest